Drawing for MARITECH

USPTO serial 79168653

MARITECH

Reviewed by CopyMark Law Group

Reg. 4948609Status 404
Filing date
Status date
Registration date
May 3, 2016
Examiner
CORDOVA, RAUL
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MARITECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey C. Joyce

Jeffrey C. Joyce Eaton PeabodyP.O. Box 15235Portland, ME 04112UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological products for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; emulsifiers for use in the manufacture of cosmetics; polymeric chemicals for use in the manufacture of cosmetics; prepared compositions of fucoidan for use in the manufacture of cosmetics; chemical ingredients for skin care preparations; chemical ingredients for use in the manufacture of foods; chemical preparations for use as ingredients for foods; ingredients used in topical dermatological products; active chemical ingredients for skin care preparations;fucoidan for use in the manufacture of cosmetics; fucoidan ingredients for skin care preparations; fucoidan ingredients for skin care preparations and dermatological preparations; active chemicals for use in coating medical apparatus, namely fucoidan; chemical substances for use in the production of drugs; chemical products of fucoidan for use in pharmaceuticals; active chemicals for use in coating pharmaceutical products; polysaccharides for use in the manufacture of pharmaceutical productsSECTION 70 - CANCELLED—
003Fucoidan extracts for cosmetic useSECTION 70 - CANCELLED—
005Extracts of seaweed or marine algae prepared for medical use; extracts of seaweed or marine algae prepared for therapeutic use; extracts of seaweed or marine algae prepared for dietary or nutritional supplement use; extracts of seaweed or marine algae having an anti-viral effect; medical therapeutic agents consisting of fucoidan; medical therapeutic biological products consisting of fucoidan; medical therapeutic biological products containing extracts of seaweed or marine algae; anti-viral agents for the treatment of viruses; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceutical preparations for topical use for the treatment of dermatological conditions; topical dermatological products for medical purposes; veterinary preparations for topical application for the treatment of dermatological conditions; natural preparations for skin treatment; medicated preparations for the skin; veterinary preparations for use in improving the skin; animal care products for veterinary use, namely fucoidan; medicated body care preparations, namely dermatological; medicated natural body care products for the skin; pharmaceutical preparations for health care; dietary supplements from plant extracts; plant extracts for medical use; plant extracts for pharmaceutical use; fucoidan extracts for nutritional supplement use; fucoidan extracts for medical use; fucoidan extracts for pharmaceutical use; fucoidan extracts for veterinary use; fucoidan extracts and related algal polysaccharides for medical use; compounds having an anti-inflammatory activity; anti-coagulants; anti-ulcer agents; epidermal growth factor preparations for the treatment of burns; epidermal growth factor preparations for the treatment of wounds; additives in the nature of dietary supplements for animals; medicines for veterinary purposes, namely fucoidan; plant compounds for use as dietary veterinary supplements; preparations of plants for veterinary use in the treatment of animals, namely fucoidan; lubricants containing fucoidan for medical use; lubricants for surgical purposes; personal sexual lubricants; gastrointestinal drugs; medical therapeutic drugs for the treatment of medical conditions; pharmaceutical preparations, namely acne cleansers; pharmaceutical preparations namely acne creams; anti-allergic pharmaceutical preparations; anti-sunburn preparations for pharmaceutical use; pharmaceutical anticoagulant preparations; pharmaceutical substances for use in aquaculture, namely fucoidan; nutritional animal feed supplements; nutritional feed supplements for animals; nutritional supplements for medical use; dietary nutritional supplements; medicated nutritional additives for animal foodstuffs; medicated preparations for use in the treatment of sunburn; natural preparations for skin treatment; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceutical preparations for use in the treatment of arthritis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in the treatment of skin blemishes; pharmaceutical products for the treatment of gastrointestinal disorders; preparations for the treatment of haemophilia; preparations for the treatment of rheumatic pain; medicated skin treatment for animals; nasal decongestants; pharmaceutical preparations for nasal use; compounds for treating respiratory diseases; anti-bacterial pharmaceutical preparations; anti-bacterial preparations for veterinary use; dietary supplements for animals; dietary supplements for infants; herbal dietary supplements; nutritional supplements; plant medicinal compounds for use as dietary supplements; plant veterinary compounds for use as dietary supplements; extracts of pharmaceutical use, namely fucoidanSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 31, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jan 31, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
May 2, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 2, 202271AGREGISTERED-SEC.71 ACCEPTED—
Apr 27, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 15, 2021ES71TEAS SECTION 71 RECEIVED—
Aug 19, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 3, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 3, 2016FIMPFINAL DISPOSITION PROCESSED—
Aug 3, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 3, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 13, 2016GPNXNOTIFICATION PROCESSED BY IB—
Jan 27, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 27, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 27, 2016NPUBNOTICE OF PUBLICATION—
Jan 8, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 31, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 30, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 30, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2015RFNTREFUSAL PROCESSED BY IB—
Jul 27, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 27, 2015RFRRREFUSAL PROCESSED BY MPU—
Jul 25, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 24, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2015DOCKASSIGNED TO EXAMINER—
Jul 15, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 11, 2015DOCKASSIGNED TO EXAMINER—
Jul 11, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance